Macquarie Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$35.1M Buy
4,807,351
+130,729
+3% +$956K 0.04% 505
2025
Q1
$44.4M Buy
4,676,622
+864,393
+23% +$8.2M 0.06% 437
2024
Q4
$62.8M Sell
3,812,229
-12,389
-0.3% -$204K 0.08% 353
2024
Q3
$56.4M Buy
3,824,618
+561,232
+17% +$8.28M 0.06% 416
2024
Q2
$45.3M Sell
3,263,386
-760,123
-19% -$10.5M 0.05% 443
2024
Q1
$63.3M Sell
4,023,509
-57,670
-1% -$907K 0.07% 361
2023
Q4
$66M Buy
4,081,179
+1,062,226
+35% +$17.2M 0.08% 358
2023
Q3
$37.1M Buy
3,018,953
+748,900
+33% +$9.21M 0.05% 488
2023
Q2
$36.5M Buy
2,270,053
+245,699
+12% +$3.95M 0.04% 527
2023
Q1
$35.2M Buy
2,024,354
+55,780
+3% +$971K 0.04% 531
2022
Q4
$18.2M Buy
1,968,574
+50,298
+3% +$465K 0.02% 706
2022
Q3
$16.5M Buy
1,918,276
+33,262
+2% +$287K 0.02% 729
2022
Q2
$15.4M Sell
1,885,014
-105,593
-5% -$861K 0.02% 759
2022
Q1
$24.2K Buy
1,990,607
+606,003
+44% +$7.36K 0.02% 722
2021
Q4
$47.2M Sell
1,384,604
-657,852
-32% -$22.4M 0.04% 533
2021
Q3
$98.5M Buy
2,042,456
+1,170,745
+134% +$56.5M 0.08% 304
2021
Q2
$39.4M Buy
871,711
+867,877
+22,636% +$39.2M 0.03% 603
2021
Q1
$185K Sell
3,834
-385
-9% -$18.6K ﹤0.01% 1724
2020
Q4
$227K Hold
4,219
﹤0.01% 1632
2020
Q3
$156K Hold
4,219
﹤0.01% 1673
2020
Q2
$131K Buy
4,219
+1,046
+33% +$32.5K ﹤0.01% 1670
2020
Q1
$88K Buy
+3,173
New +$88K ﹤0.01% 1665
2019
Q1
Sell
-863
Closed -$11K 1913
2018
Q4
$11K Buy
+863
New +$11K ﹤0.01% 1906